AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,533,000 | +25.5% | 3,952,957 | 0.0% | 1.62% | +21.9% |
| Q2 2022 | $25,931,000 | +17.4% | 3,952,957 | 0.0% | 1.33% | +108.8% |
| Q1 2022 | $22,097,000 | +19.2% | 3,952,957 | -0.0% | 0.64% | +70.1% |
| Q4 2021 | $18,539,000 | -24.1% | 3,952,958 | 0.0% | 0.38% | +29.3% |
| Q3 2021 | $24,429,000 | -6.2% | 3,952,958 | 0.0% | 0.29% | -14.5% |
| Q2 2021 | $26,050,000 | -10.0% | 3,952,958 | 0.0% | 0.34% | -47.8% |
| Q1 2021 | $28,936,000 | +26.9% | 3,952,958 | 0.0% | 0.65% | +7.8% |
| Q4 2020 | $22,809,000 | -2.9% | 3,952,958 | 0.0% | 0.60% | -39.4% |
| Q3 2020 | $23,481,000 | +15.3% | 3,952,958 | 0.0% | 0.99% | +21.5% |
| Q2 2020 | $20,358,000 | +122.8% | 3,952,958 | +56.6% | 0.82% | +71.5% |
| Q1 2020 | $9,138,000 | – | 2,524,387 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 245,606 | $3,671,810 | 6.55% |
| AIGH Capital Management LLC | 695,358 | $10,395,602 | 3.42% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 638,360 | $9,544 | 2.08% |
| Kellner Capital, LLC | 100,016 | $1,495 | 1.74% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,464,807 | $21,898,865 | 1.70% |
| Worth Venture Partners, LLC | 170,925 | $2,555,329 | 1.51% |
| Birchview Capital, LP | 100,000 | $1,495 | 1.06% |
| BCK CAPITAL MANAGEMENT LP | 68,000 | $1,016,600 | 1.05% |
| WATER ISLAND CAPITAL LLC | 698,915 | $10,449 | 0.89% |
| EHP Funds Inc. | 292,043 | $4,366 | 0.82% |